annual EBITDA:
-$420.08M-$35.22M(-9.15%)Summary
- As of today (June 1, 2025), AGIO annual EBITDA is -$420.08 million, with the most recent change of -$35.22 million (-9.15%) on December 31, 2024.
- During the last 3 years, AGIO annual EBITDA has fallen by -$50.91 million (-13.79%).
- AGIO annual EBITDA is now -2553.72% below its all-time high of -$15.83 million, reached on December 31, 2011.
Performance
AGIO EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBITDA:
-$105.35M+$18.32M(+14.81%)Summary
- As of today (June 1, 2025), AGIO quarterly EBITDA is -$105.35 million, with the most recent change of +$18.32 million (+14.81%) on March 31, 2025.
- Over the past year, AGIO quarterly EBITDA has dropped by -$14.63 million (-16.12%).
- AGIO quarterly EBITDA is now -3064.29% below its all-time high of $3.55 million, reached on September 30, 2014.
Performance
AGIO quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
-$434.71M-$14.63M(-3.48%)Summary
- As of today (June 1, 2025), AGIO TTM EBITDA is -$434.71 million, with the most recent change of -$14.63 million (-3.48%) on March 31, 2025.
- Over the past year, AGIO TTM EBITDA has dropped by -$47.95 million (-12.40%).
- AGIO TTM EBITDA is now -8594.22% below its all-time high of -$5.00 million, reached on March 31, 2012.
Performance
AGIO TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
AGIO EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -9.2% | -16.1% | -12.4% |
| 3 y3 years | -13.8% | -6.8% | -14.7% |
| 5 y5 years | -36.3% | -24.6% | -44.1% |
AGIO EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -13.8% | at low | -18.6% | +14.8% | -18.4% | at low |
| 5 y | 5-year | -36.3% | at low | -35.1% | +14.8% | -74.9% | at low |
| alltime | all time | -2553.7% | at low | -3064.3% | +14.8% | -8594.2% | at low |
AGIO EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$105.35M(-14.8%) | -$434.71M(+3.5%) |
| Dec 2024 | -$420.08M(+9.2%) | -$123.67M(+21.9%) | -$420.08M(+4.7%) |
| Sep 2024 | - | -$101.47M(-2.6%) | -$401.29M(+0.5%) |
| Jun 2024 | - | -$104.22M(+14.9%) | -$399.10M(+3.2%) |
| Mar 2024 | - | -$90.72M(-13.5%) | -$386.76M(+0.5%) |
| Dec 2023 | -$384.86M(+1.2%) | -$104.87M(+5.6%) | -$384.86M(+2.0%) |
| Sep 2023 | - | -$99.27M(+8.0%) | -$377.35M(+2.8%) |
| Jun 2023 | - | -$91.89M(+3.5%) | -$367.18M(-0.9%) |
| Mar 2023 | - | -$88.82M(-8.8%) | -$370.64M(-2.6%) |
| Dec 2022 | -$380.48M(+3.1%) | -$97.36M(+9.3%) | -$380.48M(-1.4%) |
| Sep 2022 | - | -$89.11M(-6.5%) | -$385.75M(+0.0%) |
| Jun 2022 | - | -$95.35M(-3.4%) | -$385.58M(+1.7%) |
| Mar 2022 | - | -$98.67M(-3.9%) | -$379.11M(+2.7%) |
| Dec 2021 | -$369.18M(+13.2%) | -$102.63M(+15.4%) | -$369.18M(+5.7%) |
| Sep 2021 | - | -$88.94M(+0.1%) | -$349.30M(+3.2%) |
| Jun 2021 | - | -$88.87M(+0.2%) | -$338.33M(+2.4%) |
| Mar 2021 | - | -$88.74M(+7.2%) | -$330.31M(+1.3%) |
| Dec 2020 | -$326.13M(+5.8%) | -$82.74M(+6.1%) | -$326.13M(+31.2%) |
| Sep 2020 | - | -$77.97M(-3.6%) | -$248.56M(-9.5%) |
| Jun 2020 | - | -$80.85M(-4.4%) | -$274.68M(-8.9%) |
| Mar 2020 | - | -$84.56M(+1531.4%) | -$301.66M(-3.5%) |
| Dec 2019 | -$308.18M(-9.1%) | -$5.18M(-95.0%) | -$312.59M(-18.9%) |
| Sep 2019 | - | -$104.09M(-3.5%) | -$385.40M(+1.8%) |
| Jun 2019 | - | -$107.83M(+12.9%) | -$378.67M(+10.7%) |
| Mar 2019 | - | -$95.48M(+22.4%) | -$342.05M(+0.9%) |
| Dec 2018 | -$338.86M | -$77.99M(-19.9%) | -$338.86M(-3.0%) |
| Sep 2018 | - | -$97.36M(+36.7%) | -$349.34M(+6.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2018 | - | -$71.21M(-22.8%) | -$329.38M(-3.5%) |
| Mar 2018 | - | -$92.29M(+4.3%) | -$341.19M(+8.5%) |
| Dec 2017 | -$314.36M(+61.0%) | -$88.48M(+14.3%) | -$314.36M(+11.6%) |
| Sep 2017 | - | -$77.40M(-6.8%) | -$281.57M(+5.8%) |
| Jun 2017 | - | -$83.03M(+26.8%) | -$266.25M(+11.7%) |
| Mar 2017 | - | -$65.46M(+17.5%) | -$238.38M(+22.1%) |
| Dec 2016 | -$195.28M(+69.3%) | -$55.69M(-10.3%) | -$195.28M(+8.9%) |
| Sep 2016 | - | -$62.08M(+12.5%) | -$179.34M(+14.5%) |
| Jun 2016 | - | -$55.17M(+146.8%) | -$156.69M(+17.9%) |
| Mar 2016 | - | -$22.35M(-43.8%) | -$132.88M(+15.2%) |
| Dec 2015 | -$115.36M(+118.6%) | -$39.75M(+0.8%) | -$115.36M(+13.1%) |
| Sep 2015 | - | -$39.43M(+25.8%) | -$101.97M(+72.9%) |
| Jun 2015 | - | -$31.35M(+549.8%) | -$58.99M(+29.3%) |
| Mar 2015 | - | -$4.83M(-81.7%) | -$45.64M(-13.5%) |
| Dec 2014 | -$52.77M(+40.9%) | -$26.36M(-841.8%) | -$52.77M(+37.8%) |
| Sep 2014 | - | $3.55M(-119.7%) | -$38.30M(-27.1%) |
| Jun 2014 | - | -$18.00M(+50.6%) | -$52.55M(+23.1%) |
| Mar 2014 | - | -$11.95M(+0.4%) | -$42.70M(+14.0%) |
| Dec 2013 | -$37.44M(+71.6%) | -$11.90M(+11.3%) | -$37.44M(+18.1%) |
| Sep 2013 | - | -$10.69M(+31.2%) | -$31.71M(+22.9%) |
| Jun 2013 | - | -$8.15M(+21.7%) | -$25.81M(+9.8%) |
| Mar 2013 | - | -$6.70M(+8.5%) | -$23.51M(+7.8%) |
| Dec 2012 | -$21.82M(+37.8%) | -$6.17M(+28.9%) | -$21.82M(+39.5%) |
| Sep 2012 | - | -$4.79M(-18.1%) | -$15.64M(+44.2%) |
| Jun 2012 | - | -$5.85M(+17.0%) | -$10.85M(+117.0%) |
| Mar 2012 | - | -$5.00M | -$5.00M |
| Dec 2011 | -$15.83M | - | - |
FAQ
- What is Agios Pharmaceuticals annual EBITDA?
- What is the all time high annual EBITDA for Agios Pharmaceuticals?
- What is Agios Pharmaceuticals annual EBITDA year-on-year change?
- What is Agios Pharmaceuticals quarterly EBITDA?
- What is the all time high quarterly EBITDA for Agios Pharmaceuticals?
- What is Agios Pharmaceuticals quarterly EBITDA year-on-year change?
- What is Agios Pharmaceuticals TTM EBITDA?
- What is the all time high TTM EBITDA for Agios Pharmaceuticals?
- What is Agios Pharmaceuticals TTM EBITDA year-on-year change?
What is Agios Pharmaceuticals annual EBITDA?
The current annual EBITDA of AGIO is -$420.08M
What is the all time high annual EBITDA for Agios Pharmaceuticals?
Agios Pharmaceuticals all-time high annual EBITDA is -$15.83M
What is Agios Pharmaceuticals annual EBITDA year-on-year change?
Over the past year, AGIO annual EBITDA has changed by -$35.22M (-9.15%)
What is Agios Pharmaceuticals quarterly EBITDA?
The current quarterly EBITDA of AGIO is -$105.35M
What is the all time high quarterly EBITDA for Agios Pharmaceuticals?
Agios Pharmaceuticals all-time high quarterly EBITDA is $3.55M
What is Agios Pharmaceuticals quarterly EBITDA year-on-year change?
Over the past year, AGIO quarterly EBITDA has changed by -$14.63M (-16.12%)
What is Agios Pharmaceuticals TTM EBITDA?
The current TTM EBITDA of AGIO is -$434.71M
What is the all time high TTM EBITDA for Agios Pharmaceuticals?
Agios Pharmaceuticals all-time high TTM EBITDA is -$5.00M
What is Agios Pharmaceuticals TTM EBITDA year-on-year change?
Over the past year, AGIO TTM EBITDA has changed by -$47.95M (-12.40%)